TrianglePUBLICATIONS · 37724607
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Med
- Publication date
- 2023 Sep
- First author
- Peretz Soroka H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Peretz Soroka H
- type
- Author
- name
- Vora T
- type
- Author
- name
- Noujaim J
- type
- Author
- name
- Marcoux N
- type
- Author
- name
- Cohen-Gogo S
- type
- Author
- name
- Alcindor T
- type
- Author
- name
- Holloway C
- type
- Author
- name
- Rodrigues C
- type
- Author
- name
- Karachiwala H
- type
- Author
- name
- Alvi S
- type
- Author
- name
- Lee U
- type
- Author
- name
- Cheng S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Peretz Soroka H
- type
- Author
- name
- Vora T
- type
- Author
- name
- Noujaim J
- type
- Author
- name
- Marcoux N
- type
- Author
- name
- Cohen-Gogo S
- type
- Author
- name
- Alcindor T
- type
- Author
- name
- Holloway C
- type
- Author
- name
- Rodrigues C
- type
- Author
- name
- Karachiwala H
- type
- Author
- name
- Alvi S
- type
- Author
- name
- Lee U
- type
- Author
- name
- Cheng S
- type
- Author
- bibliography ids
- nci-bib-d67b0492da2c9c83f1c13429
- book metadata
- content sha256
- 0b03ea1a5a2154da38a5f4f60e43bb5efaa233408f6c5baa717c60bcd72d9bd2
- document type
- citation
- dois
- 10.1002/cam4.6515
- electronic publication date
- display
- 2023 Sep 19
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37724607
- immutable id
- pubmed:37724607@0b03ea1a5a2154da38a5f4f60e43bb5efaa233408f6c5baa717c60bcd72d9bd2
- journal
- abbreviation
- Cancer Med
- issn electronic
- 2045-7634
- issn print
- Source null
- issue
- 18
- name
- Cancer medicine
- nlm unique id
- 101595310
- pages
- 18872-18881
- volume
- 12
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37724607
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- 52af5fb980dd87af1ab594cd8cfb1df0aeba65ecf23cda79c635dd1061ac2d42
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Sep
- precision
- month
- year
- 2023
- publication types
- Multicenter Study
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Preserved source evidence · Not medical advice